Literature DB >> 11588989

Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders.

P Santavuori1, S L Vanhanen, T Autti.   

Abstract

Early diagnosis is mandatory for avoiding further cases in families with hereditary metabolic brain disorders. This review lists the most important clinical symptoms and neuroradiological findings at the early stage of the seven most common childhood neuronal ceroid lipofuscinoses (NCL) types. In the infantile type the typical magnetic resonance imaging (MRI) findings can be seen even before the clinical signs. In the classic late infantile type (CLN2), MRI is less informative but in this and in the variant late infantile type CLN6 the characteristic neurophysiological findings are present at an early stage, although not in the Finnish variant CLN5. In the latter, the clinical diagnosis depends on ophthalmological and MRI findings. The combination of ophthalmological deficits and vacuolated lymphocytes is highly characteristic of the juvenile type (CLN3). A new NCL type, Northern epilepsy (CLN8), is also briefly reviewed.

Entities:  

Mesh:

Year:  2001        PMID: 11588989     DOI: 10.1053/ejpn.2000.0454

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  14 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients.

Authors:  María-Socorro Pérez-Poyato; Montserrat Milà Recansens; Isidre Ferrer Abizanda; Raquel Montero Sánchez; Laia Rodríguez-Revenga; Victoria Cusí Sánchez; M Mar García González; Rosario Domingo Jiménez; Rafael Camino León; Ramón Velázquez Fragua; Antonio Martínez-Bermejo; Mercè Pineda Marfà
Journal:  J Inherit Metab Dis       Date:  2011-04-16       Impact factor: 4.982

3.  Congenital CLN disease in two siblings.

Authors:  Sascha Meyer; Umut Yilmaz; Yoo-Jin Kim; Robert Steinfeld; Gabriele Meyberg-Solomayer; Barbara Oehl-Jaschkowitz; Andreas Tzschach; Ludwig Gortner; Julia Igel; Otto Schofer
Journal:  Wien Med Wochenschr       Date:  2015-06-10

4.  Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre.

Authors:  G Anderson; V V Smith; M Malone; N J Sebire
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

5.  JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence.

Authors:  Taina H Autti; Janne Hämäläinen; Minna Mannerkoski; Koen Van Van Leemput; Laura E Aberg
Journal:  J Neurol       Date:  2008-07-17       Impact factor: 4.849

6.  Quantitative t2 measurements in juvenile and late infantile neuronal ceroid lipofuscinosis.

Authors:  Alvaro Paniagua Bravo; N D Forkert; A Schulz; U Löbel; J Fiehler; X Ding; J Sedlacik; M Rosenkranz; E Goebell
Journal:  Clin Neuroradiol       Date:  2012-12-23       Impact factor: 3.649

7.  Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging.

Authors:  J P Dyke; H U Voss; D Sondhi; N R Hackett; S Worgall; L A Heier; B E Kosofsky; A M Uluğ; D C Shungu; X Mao; R G Crystal; D Ballon
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

Review 8.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

9.  Metabolic causes of epileptic encephalopathy.

Authors:  Joe Yuezhou Yu; Phillip L Pearl
Journal:  Epilepsy Res Treat       Date:  2013-05-22

10.  Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Grace Robinson Kick; Elizabeth J Meiman; Julianna C Sabol; Rebecca E H Whiting; Juri Ota-Kuroki; Leilani J Castaner; Cheryl A Jensen; Martin L Katz
Journal:  Exp Eye Res       Date:  2021-06-30       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.